权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Abl Kinases in growth factor signaling, motility, and invasion

Abl 激酶在生长因子信号传导、运动和侵袭中的作用

基本信息

批准号：
8123233
负责人：
RINA PLATTNER
金额：
$ 25.95万
依托单位：
UNIVERSITY OF KENTUCKY
依托单位国家：
美国
项目类别：
财政年份：
2007
资助国家：
美国
起止时间：
2007-08-01 至 2013-07-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/8123233
关键词：
Adhesions Affect Animals Basement membrane Biochemical Biological Biological Assay Blood Blood Vessels Breast Cancer Cell Cancer Etiology Cancer cell line Cell Line Cell Proliferation Cells Cessation of life Chemotaxis Cultured Tumor Cells Cytoskeletal Modeling Data Development Distant Dominant-Negative Mutation Drug Combinations Epidermal Growth Factor Receptor Family Fatty acid glycerol esters Fibroblasts Goals Growth Factor Growth Factor Receptors Immigration Immune In Vitro Invaded Label Location MAP Kinase Gene Malignant Neoplasms Mammary Gland Parenchyma Mammary Neoplasms Mammary gland Matrix Metalloproteinases Mediating Metalloproteases Metastatic Lesion Molecular Mus Neoplasm Metastasis Normal tissue morphology Organ PTK2 gene PTPN11 gene Pathway interactions Pharmaceutical Preparations Phosphotransferases Platelet-Derived Growth Factor Receptor Play Primary Neoplasm Process Proliferating Protein Tyrosine Kinase Proteins RNA Interference Regulation Resistance development Role Signal Transduction Site Solid Neoplasm Stream Tail Testing Translating Tumor Cell Invasion Veins base cell motility fluorescence imaging in vivo inhibitor/antagonist insight kinase inhibitor leukemia malignant breast neoplasm migration mortality prevent research study rho src-Family Kinases tumor tumor progression

项目摘要

DESCRIPTION (provided by applicant): Growth factors modulate cell proliferation, migration, and survival. Precise regulation of these processes is critical as deregulated growth factor signaling increases cellular migration and drives tumor invasion and metastasis, the major cause of cancer-related deaths. Although Abl nonreceptor tyrosine kinases initiate leukemia development, their role in the development or progression of solid tumors has not been studied. Previously, we showed that Abl kinases are activated downstream of growth factor receptors via Src family kinases and PLC-yl, and influence growth factor-mediated cytoskeletal reorganization and migration in fibroblasts. Deregulation of growth factor receptors, Src kinases and PLC-yl in solid tumors, such as breast cancer, drives tumor invasion and metastasis. Our studies demonstrate that the Abl kinases are dramatically activated downstream of activated growth factor receptors and Src kinases in highly aggressive breast cancer cell lines, and promote breast cancer invasion. Based on these findings, the overall objective of this proposal is to characterize the conditions leading to Abl kinase activation in breast cancer, and to define invasion-promoting signaling cascades controlled by the Abl kinases. We hypothesize that Abl family kinases translate and direct growth factor receptor and Src kinase-mediated signals to influence breast cancer invasion and metastasis. Three Specific Aims are described to evaluate this hypothesis: 1) Determine the conditions that activate the Abl kinases in breast cancer; 2) Identify biological and molecular mechanisms by which Abl kinases promote breast cancer cell invasion; and 3) Determine whether activation of the Abl kinases promotes breast cancer metastasis, in vivo. To achieve our goal, we will combine biochemical, molecular, cellular, and whole animal approaches using: 1) primary breast tissue, breast cancer cell lines; RNAi, and inhibitors to identify mechanisms and conditions of Abl activation; 2) RNAi, chemotaxis, invasion, and zymography assays to identify mechanisms by which Abl kinases promote invasion; and 3) in vivo metastasis studies to assess whether activation of the Abl kinases promotes metastasis in immune- compromised mice. These data are likely to provide mechanistic insight into how abnormal regulation of the Abl kinases contributes to breast cancer progression, which may aid in the discovery of new drug combinations for preventing breast cancer metastasis and decreasing mortality.

描述（由申请方提供）：生长因子调节细胞增殖、迁移和存活。这些过程的精确调节是至关重要的，因为失调的生长因子信号传导增加细胞迁移并驱动肿瘤侵袭和转移，这是癌症相关死亡的主要原因。虽然Abl非受体酪氨酸激酶启动白血病的发展，但其在实体瘤的发展或进展中的作用尚未研究。以前，我们表明，Abl激酶通过Src家族激酶和PLC-yl在生长因子受体下游被激活，并影响成纤维细胞中生长因子介导的细胞骨架重组和迁移。实体瘤（如乳腺癌）中生长因子受体、Src激酶和PLC-γ 1的失调驱动肿瘤侵袭和转移。我们的研究表明，在高度侵袭性乳腺癌细胞系中，Abl激酶在活化的生长因子受体和Src激酶的下游被显著活化，并促进乳腺癌的侵袭。基于这些发现，本提案的总体目标是表征导致乳腺癌中Abl激酶激活的条件，并定义由Abl激酶控制的促进侵袭的信号级联。我们假设Abl家族激酶翻译并指导生长因子受体和Src激酶介导的信号，从而影响乳腺癌的侵袭和转移。描述了三个具体目的以评估该假设：1）确定在乳腺癌中激活Abl激酶的条件; 2）鉴定Abl激酶促进乳腺癌细胞侵袭的生物学和分子机制;和3）确定Abl激酶的激活是否促进体内乳腺癌转移。为了实现我们的目标，我们将联合收割机结合生物化学、分子、细胞和整体动物方法，使用：1）原代乳腺组织、乳腺癌细胞系; RNAi和抑制剂，以鉴定Abl激活的机制和条件; 2）RNAi、趋化性、侵袭和酶谱分析，以鉴定Abl激酶促进侵袭的机制;和3）体内转移研究，以评估Abl激酶的活化是否促进免疫受损小鼠的转移。这些数据很可能提供机制洞察Abl激酶的异常调节如何有助于乳腺癌的进展，这可能有助于发现新的药物组合，用于预防乳腺癌转移和降低死亡率。